‘Small victory’ for Bayer: Judge says firm can move upcoming glyphosate trials to farm states

file j abc
Image: shutterstock.com

In a win for Monsanto following more than $2 billion in cancer-trial losses in California against the company’s popular weed killer Roundup, the federal judge overseeing nationwide litigation over the product said [May 22] Monsanto can choose where upcoming cases will be tried.

The tentative bench ruling by U.S. District Judge Vince Chhabria could help Bayer AG-owned Monsanto win future cases by trying them in agricultural states where farmers heavily depend on the company’s glyphosate-based herbicides Roundup and Ranger Pro.

With roughly 13,400 cases pending in the multidistrict litigation in San Francisco, Chhabria had proposed sending them back to their home districts for trial in phases, starting with 16 cases filed in California. Cases filed in other states would be transferred in subsequent phases.

Related article:  China approves import of 5 GMO crops for animal feed, first since 2017

The proposal comes after a federal jury awarded plaintiff Ed Hardeman $80 million in the first bellwether trial before Chhabria in San Francisco in March. Hardeman claimed decades of Roundup use had caused his non-Hodgkin lymphoma.

ADVERTISEMENT

Read full, original article: Monsanto Gains Small Victory After Losing 3 Roundup Trials

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
seralinistud

Gilles-Éric Séralini: Activist professor and face of anti-GMO industry

The French biologist and his research team--funded by the Rodale ...
vandana shiva

Vandana Shiva: ‘Rock Star’ of GMO protest movement has anti-science history

In a 2012 interview, Bill Moyers referred to Vandana Shiva as ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend